Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricGSKGSK plcSNYSanofi SABMYBristol Myers Squibb
Snapshot
Price$50.83$43.73$60.77
Market cap$102.51B$98.73B$118.71B
Valuation
P/E13.8x7.4x20.8x
Forward P/E9.8x5.3x16.5x
Growth
Revenue growth4.0%43.7%1.8%
EPS growth86.7%96.2%26.3%
Profitability
Net margin17.8%17.2%12.3%
ROE35.8%17.0%41.6%
Balance sheet & cash
Debt / equity1.08x0.28x2.44x
Free cash flow yield3.8%21.4%15.4%
Dividend yield3.5%5.4%4.5%
Verdict
Investment ratingFavorable· 66Strong· 80Favorable· 60

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearGSKtoday $51SNYtoday $44BMYtoday $61
2027$71.19 – $104.41+105% CAGR$64.35 – $94.38+116% CAGR$57.55 – $84.41+39% CAGR
2028$132.93 – $194.96+96% CAGR$126.25 – $185.17+106% CAGR$72.67 – $106.58+32% CAGR
2029$248.21 – $364.05+93% CAGR$247.71 – $363.30+103% CAGR$91.76 – $134.58+30% CAGR
2030$463.49 – $679.78+91% CAGR$486.00 – $712.80+101% CAGR$115.86 – $169.93+29% CAGR
2031$865.47 – $1,269.36+90% CAGR$953.53 – $1,398.52+100% CAGR$146.30 – $214.58+29% CAGR
5-yr CAGR76.3% – 90.3%85.2% – 100.0%19.2% – 28.7%